IP Library Granted Patent US 9,333,277
Granted Patent B2
US 9,333,277 · App. 14/306,368 · Granted May 10, 2016

Extracellular matrix (ECM) structures for tissue regeneration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,277
App. No.
14/306,368
Granted
May 10, 2016
Kind
B2
Abstract

An extracellular matrix (ECM) structure for tissue regeneration, the ECM structure having a a sheet member comprising small intestine submucosa (SIS), the SIS sheet member being folded and laminated proximate the sheet member edge, wherein a folded laminated ECM structure having a cavity therein is formed, the ECM structure further including an ECM composition that is disposed in the ECM structure cavity, the ECM composition including liver basement membrane, urinary bladder submucosa, a mesenchymal stem cell and a growth factor.

Claims (28)

1. An extracellular matrix (ECM) structure for tissue regeneration, comprising:

a sheet member comprising first acellular ECM from a first mammalian tissue source, said first mammalian tissue source comprising small intestine submucosa (SIS),

said SIS sheet member having a periphery, an edge that extends around said SIS sheet member periphery, a first end and an opposing second end, said SIS sheet member further including a mid-region that is disposed between said first and second ends,

said SIS sheet member being folded proximate said mid-region, wherein said first end is adjacent said second end, and laminated proximate said edge, wherein a folded laminated ECM structure having a cavity therein is formed,

said folded laminated ECM structure further comprising an ECM composition comprising second acellular ECM from a second mammalian tissue source, third acellular ECM from a third mammalian tissue source, a mesenchymal stem cell and a growth factor,

said second mammalian tissue source comprising liver basement membrane, said third mammalian tissue source comprising urinary bladder submucosa, said growth factor comprising fibroblast growth factor-2 (FGF-2),

said ECM composition being disposed in said folded laminated ECM structure cavity.

2. An extracellular matrix (ECM) structure for tissue regeneration, comprising:

a sheet member comprising first ECM, said first ECM comprising small intestine submucosa (SIS),

said SIS sheet member having a periphery, an edge that extends around said SIS sheet member periphery, a first end and an opposing second end, said SIS sheet member further including a mid-region that is disposed between said first and second ends,

said SIS sheet member being folded proximate said mid-region, wherein said first end is adjacent said second end, and laminated proximate said edge, wherein a folded laminated ECM structure having a cavity therein is formed,

said folded laminated ECM structure further comprising an ECM composition comprising second acellular ECM from a second mammalian tissue source, third acellular ECM from a third mammalian tissue source, a mesenchymal stem cell and a growth factor,

said second mammalian tissue source comprising liver basement membrane, said third mammalian tissue source comprising urinary bladder submucosa, said growth factor comprising a vascular epithelial growth factor (VEGF),

said ECM composition being disposed in said folded laminated ECM structure cavity.

3. An extracellular matrix (ECM) structure for tissue regeneration, comprising:

a sheet member comprising first ECM, said first ECM comprising small intestine submucosa (SIS),

said SIS sheet member having a periphery, an edge that extends around said SIS sheet member periphery, a first end and an opposing second end, said SIS sheet member further including a mid-region that is disposed between said first and second ends,

said SIS sheet member being folded proximate said mid-region, wherein said first end is adjacent said second end, and laminated proximate said edge, wherein a folded laminated ECM structure having a cavity therein is formed,

said folded laminated ECM structure further comprising an ECM composition comprising second acellular ECM from a second mammalian tissue source, third acellular ECM from a third mammalian tissue source, a pluripotent cell and a growth factor,

said second mammalian tissue source comprising liver basement membrane, said third mammalian tissue source comprising urinary bladder submucosa, said growth factor comprising fibroblast growth factor-2 (FGF-2),

said ECM composition being disposed in said folded laminated ECM structure cavity.

4. An extracellular matrix (ECM) structure for tissue regeneration, comprising:

a sheet member comprising first ECM, said first ECM comprising small intestine submucosa (SIS),

said SIS sheet member having a periphery, an edge that extends around said SIS sheet member periphery, a first end and an opposing second end, said SIS sheet member further including a mid-region that is disposed between said first and second ends,

said SIS sheet member being folded proximate said mid-region, wherein said first end is adjacent said second end, and laminated proximate said edge, wherein a folded laminated ECM structure having a cavity therein is formed,

said folded laminated ECM structure further comprising an ECM composition comprising second acellular ECM from a second mammalian tissue source, third acellular ECM from a third mammalian tissue source, a pluripotent cell and a growth factor,

said second mammalian tissue source comprising liver basement membrane, said third mammalian tissue source comprising urinary bladder submucosa, said growth factor comprising a vascular epithelial growth factor (VEGF),

said ECM composition being disposed in said folded laminated ECM structure cavity.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2025
From: SWK FUNDING LLC
To: ELUTIA INC. (F/K/A AZIYO BIOLOGICS, INC.); ELUTIA MED LLC (F/K/A AZIYO MED, LLC)
Reel/Frame 072468/0896 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO BIOLOGICS, INC.
To: ELUTIA INC.
Reel/Frame 064923/0361 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO MED, LLC
To: ELUTIA MED LLC
Reel/Frame 064923/0704 →
SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: SWK FUNDING LLC
Reel/Frame 060792/0045 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061161/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061164/0532 →
SEURITY INTEREST (TERM) Recorded Aug 2, 2017
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043413/0942 →
SECURITY INTEREST (REVOLVING) Recorded Aug 2, 2017
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043414/0001 →
RELEASE OF SECURITY INTEREST Recorded Jun 2, 2017
From: MIDCAP FINANCIAL TRUST
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 042669/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: CORMATRIX CARDIOVASCULAR, INC.
To: AZIYO MED, LLC
Reel/Frame 042577/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 29, 2016
From: MATHENY, ROBERT G
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 037853/0706 →
SECURITY INTEREST Recorded Sep 30, 2015
From: CORMATRIX CARDIOVASCULAR, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 036732/0103 →